Saamya Biotech (India) Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales/income from operation (net of excise duty) of nill against INR 67,314,705 a year ago. Loss from operations before other income, interest & exceptional items was INR 2,566,056 against INR 2,391,654 a year ago. Loss from ordinary activities before tax was INR 2,569,119 against INR 2,408,200 a year ago. Net loss for the period was INR 2,569,119 or INR 0.10 per basic and diluted share before and after extraordinary items against INR 2,408,200 or INR 0.10 per basic and diluted share before and after extraordinary items a year ago.